FDA Oncologic Drugs Advisory Committee to Review Status of Six Indications Granted Accelerated Approval

San Francisco, CA (UroToday.com) — The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research: